Thus, our findings demonstrate the novel function of the CK2α-DUB3 axis in tumor progression by stabilizing YAP1 and highlight that targeting this axis might be an appealing strategy in human cancers with the aberrantly upregulated YAP1. This evidence concerns the gene USP17L2 and cancer.